VKH
DARE icon

Virtu KCG Holdings’s Dare Bioscience DARE Stock Holding History

Virtu KCG Holdings’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$66K Sell
1,248
-5,259
-81% -$306K ﹤0.01% 2527
2017
Q1 		$634K Buy
6,507
+6,311
+3,220% +$911K 0.02% 1133
2016
Q4 		$17K Sell
196
-192
-49% -$18.3K ﹤0.01% 3252
2016
Q3 		$49K Buy
+388
New +$86.9K ﹤0.01% 2785

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
KWM
Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return

Virtu KCG Holdings's DARE Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Dare Bioscience (DARE) stake by 81% in Q2 2017, selling an estimated $306K and leaving 1,248 shares worth $66K. The position accounts for ﹤0.01% of the portfolio, ranked #2527.

Virtu KCG Holdings first reported a position in DARE in Q3 2016 and has held it in 4 quarters since. The position peaked at $634K in Q1 2017. 19 funds tracked by Wall St. Rank hold DARE as of Q2 2017.

  • Virtu KCG Holdings held 1,248 shares of Dare Bioscience worth $66K as of Q2 2017.
  • Virtu KCG Holdings sold 5,259 Dare Bioscience shares in Q2 2017, an estimated $306K.
  • Dare Bioscience made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2527 holding.
  • Virtu KCG Holdings first reported a position in Dare Bioscience in Q3 2016 and has held it in 4 quarters since.
  • Virtu KCG Holdings's Dare Bioscience position peaked at $634K in Q1 2017.
  • 19 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.